Elanco Animal Health Soars Past 52-Week High On Strong Sales, Raised Annual Outlook
1. Elanco’s Q2 2025 EPS was 26 cents, exceeding guidance and estimates. 2. Revenue increased to $1.24 billion, surpassing estimates and guidance. 3. Pet Health revenue rose 11%; new products drove growth. 4. Full-year guidance raised to $4.57-$4.62 billion following strong performance. 5. Stock surged to 52-week high, trading at $16.34 post-results.